Reaction Biology provides scientists worldwide with a trusted research partner supporting all phases of preclinical drug discovery from target validation through hit identification, hit to lead and lead optimization. Our portfolio covers most of your needs in drug discovery – over 1,000 biochemical targets, hundreds of cell-based assays, an extensive array of in vivo oncology models, along with custom assay development and protein production. Our team of Ph.D. scientists will provide you with collaborative support, quality data, and excellent communication, for a superior research result.

Our target categories include kinases, epigenetic targets, KRAS, proteases, and many more. We also offer a line of high-quality epigenetic and kinase proteins for sale. Assay platforms include radiolabeled and fluorescent biochemical assays, biophysical assays, ion channel, cell-based assays including a wide array of target engagement assays, and in vivo oncology models including our SubQperior tumor models.

We also specialize in developing, validating and performing bioanalytical assays in Pharmacology and Toxicology, with particular expertise in potency, safety and other assays under GMP for biopharmaceuticals, including therapeutic antibodies, hormones and cytokines. We also offer expertise in customized peptide syntheses and peptide-specific antibodies.

From our labs in the US and Germany, Reaction Biology performs research projects for customers around the globe on a fee-for-service basis and as an integrated partner, and we would be delighted to support your research needs, too. Let’s discover together.